Latest news
Loading news…
Ceregene is a biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Ceregene on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Ceregene was acquired by Sangamo Therapeutics in 2013.
Total Funding
$71.5M
Funding Rounds
3
Last Funding
Acquisitions
0
Monthly Visits
Contacts
2
About Ceregene
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Ceregene Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
2
professional contacts at Ceregene
Contact execs at Ceregene →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Ceregene
Loading news…
FAQs about Ceregene
People who checked this page also checked these
Browse the full Acquirezy directory.